Facilitative Effects of Add-on Therapy with Tadalafil in Stone Passage After Shockwave Lithotripsy; A Randomized Clinical Trial
This randomized clinical trial found that while adding tadalafil to tamsulosin did not significantly improve stone passage rates or time after shockwave lithotripsy, it did significantly reduce pain scores and the duration of hematuria with negligible additional side effects.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Kidney stones are a painful reality for millions of people, acting as jagged obstacles that block the narrow tubes carrying urine from the kidneys to the bladder. When these stones are too large to pass on their own, doctors often use a non-invasive procedure called shock wave lithotripsy. This technique focuses high-energy sound waves from outside the body onto the stone, shattering it into tiny fragments that can then be flushed out naturally. While breaking the stone is the first step, the journey of those fragments through the urinary tract can still be difficult and painful. To help the body move these pieces along, doctors frequently prescribe medications that relax the muscles in the urinary tract, making the path smoother. For years, a drug called tamsulosin has been the standard choice for this purpose, but researchers have wondered if adding a second type of medication could make the process even easier for patients.
A team of researchers at Kerman University of Medical Sciences decided to test whether adding tadalafil, a drug known for relaxing smooth muscles, to the standard treatment would improve the experience for patients after their stones were shattered. They recruited 160 adults who had just undergone the shock wave procedure for stones in their kidneys or upper ureters. The study was designed as a double-blind trial, meaning neither the patients nor the doctors knew who was receiving which medication until the study was over. Half of the participants received the standard dose of tamsulosin along with a harmless placebo pill that looked identical to the real drug. The other half received the same tamsulosin but took a daily dose of tadalafil instead of the placebo. The goal was to see if this combination helped the stone fragments leave the body faster, reduced the pain associated with their passage, or lowered the amount of bleeding that often occurs after the procedure.
The results showed that the combination of drugs did not speed up the actual removal of the stones. On average, patients in both groups took about the same amount of time to become completely free of stone fragments, with the treatment group taking roughly 2.56 days and the control group taking 2.80 days. The rate at which patients became stone-free was also nearly identical, with about 66 percent of those taking the combination drug clearing their stones compared to 61 percent of those taking only tamsulosin. This suggests that adding tadalafil does not make the body expel the stone fragments any more quickly than the standard treatment alone.
However, the study found a clear benefit in how the patients felt during the recovery process. While the duration of pain was similar in both groups, the total amount of pain experienced was significantly lower for those taking the combination therapy. Patients in the group receiving tadalafil reported a much lower overall pain score compared to those who did not. Furthermore, the bleeding, known as hematuria, which is a common side effect of passing stone fragments, lasted for a shorter time in the treatment group. Those taking both drugs experienced bleeding for an average of 2.55 days, whereas the control group experienced it for over three days. The researchers also noted that the combination treatment did not cause any new or severe side effects, with mild issues like headaches or dizziness appearing at similar rates in both groups.
The findings suggest that while adding tadalafil to the standard treatment does not change the speed at which kidney stone fragments leave the body, it does make the recovery process more comfortable. Patients who took the extra medication experienced less overall pain and less bleeding, without suffering from additional risks. The researchers concluded that this combination could be a useful addition to the treatment plan, not because it clears the stones faster, but because it reduces the physical toll of the recovery. This offers a practical way to improve the patient experience after a procedure that is already effective at breaking up the stones, providing relief from the discomfort that often follows.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.